{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:07:50Z","timestamp":1787850470143,"version":"build-2784847793"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023674","name":"Deanship of Scientific Research, King Khalid University","doi-asserted-by":"publisher","award":["RGP2\/232\/44"],"award-info":[{"award-number":["RGP2\/232\/44"]}],"id":[{"id":"10.13039\/501100023674","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.biopha.2023.115512","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T06:29:11Z","timestamp":1694932151000},"page":"115512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Harnessing role of sesamol and its nanoformulations against neurodegenerative diseases"],"prefix":"10.1016","volume":"167","author":[{"given":"Navneet","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukriti","family":"Vishwas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmanpreet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Violina","family":"Kakoty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rubiya","family":"Khursheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.V.N.L.","family":"Chaitanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molakpogu Ravindra","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Awasthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leander","family":"corrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vancha","family":"Harish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palakurthi","family":"Yanadaiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amr","family":"El-Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iftikhar","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Kensara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nehmat","family":"Ghaboura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Algahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attalla F.","family":"El-kott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Dua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed M.","family":"Abdel-Daim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2023.115512_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1242\/dmm.030205","article-title":"Neurodegenerative disease: models, mechanisms, and a new hope","volume":"10","author":"Gitler","year":"2017","journal-title":"DMM Dis. Model. Mech."},{"key":"10.1016\/j.biopha.2023.115512_bib2","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.3390\/cells11193095","article-title":"Nose-to-Brain: the next step for stem cell and biomaterial therapy in neurological disorders","volume":"11","author":"Villar-G\u00f3mez","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2023.115512_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41582-020-0333-7","article-title":"Protein transmission in neurodegenerative disease","volume":"16","author":"Peng","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2023.115512_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnins.2018.00342","article-title":"Mitochondrial quality control in neurodegenerative diseases: Focus on Parkinson\u2019s disease and Huntington\u2019s disease","volume":"12","author":"Franco-Iborra","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.biopha.2023.115512_bib5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejphar.2019.05.008","article-title":"Sesamol, a major lignan in sesame seeds (Sesamum indicum): anti-cancer properties and mechanisms of action","volume":"855","author":"Majdalawieh","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115512_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/plants12051168","article-title":"Formulation strategies for enhancing pharmaceutical and nutraceutical potential of sesamol: a natural phenolic bioactive","volume":"12","author":"Nair","year":"2023","journal-title":"Plants"},{"key":"10.1016\/j.biopha.2023.115512_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/nu14194079","article-title":"Sesame (Sesamum indicum L.): a comprehensive review of nutritional value, phytochemical composition, health benefits, development of food, and industrial applications","volume":"14","author":"Wei","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2023.115512_bib8","doi-asserted-by":"crossref","first-page":"988","DOI":"10.2174\/1389557520666200313120419","article-title":"An appraisal of current pharmacological perspectives of sesamol: a review","volume":"20","author":"Bosebabu","year":"2020","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2023.115512_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26040883","article-title":"Lignans of sesame (Sesamum indicum l.): a comprehensive review","volume":"26","author":"Andargie","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115512_bib10","doi-asserted-by":"crossref","first-page":"9566","DOI":"10.1021\/acsomega.0c00898","article-title":"Computationally designed sesamol derivatives proposed as potent antioxidants","volume":"5","author":"Castro-Gonz\u00e1lez","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.biopha.2023.115512_bib11","doi-asserted-by":"crossref","first-page":"756","DOI":"10.2174\/1389557522666220523112027","article-title":"The role of sesamin in targeting neurodegenerative disorders: a systematic review","volume":"23","author":"Ghaderi","year":"2022","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.biopha.2023.115512_bib12","unstructured":"3,4-Methylenedioxyphenol | C7H6O3 | CID 68289 - PubChem, (n.d.). \u3008https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/sesamol#section=2D-Structure\u3009 (accessed August 28, 2023)."},{"key":"10.1016\/j.biopha.2023.115512_bib13","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1039\/C9FO01873E","article-title":"Sesamol: a powerful functional food ingredient from sesame oil for cardioprotection","volume":"11","author":"Jayaraj","year":"2020","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2023.115512_bib14","unstructured":"M. Sharma, D.P. Patel, Focused microwave assisted extraction setup and extraction of sesamol from sesame seed, (2022)."},{"key":"10.1016\/j.biopha.2023.115512_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules27144663","article-title":"Involvement of resveratrol against brain cancer: a combination strategy with a pharmaceutical approach","volume":"27","author":"Karthika","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115512_bib16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.22214\/ijraset.2022.40002","article-title":"An overview on nutritional composition and therapeutic benefits of sesame seeds (Sesamum indicum)","volume":"10","author":"Mohammed","year":"2022","journal-title":"Int. J. Res. Appl. Sci. Eng. Technol."},{"key":"10.1016\/j.biopha.2023.115512_bib17","unstructured":"Alzheimer\u2019s & Dementia Help | INDIA | Alzheimer\u2019s Association, (n.d.). \u3008https:\/\/www.alz.org\/in\/dementia-alzheimers-en.asp\u3009 (accessed August 28, 2023)."},{"key":"10.1016\/j.biopha.2023.115512_bib18","unstructured":"2022 Alzheimer\u2019s Disease Facts and Figures, Alzheimer\u2019s Assoc. (2022) 1\u2013117. file:\/\/\/C:\/Users\/Sukriti Vishwas\/Downloads\/alzheimers-facts-and-figures.pdf."},{"key":"10.1016\/j.biopha.2023.115512_bib19","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","article-title":"Synergy between amyloid-\u03b2 and tau in Alzheimer\u2019s disease","author":"Busche","year":"2020","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.biopha.2023.115512_bib20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ibra.12023","article-title":"The role of microglia in Alzheimer\u2019s disease and progress of treatment","volume":"8","author":"Guan","year":"2022","journal-title":"Ibrain"},{"key":"10.1016\/j.biopha.2023.115512_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/alz.060189","article-title":"Multiple target\u2010based combination therapy of galantamine, memantine and fisetin for the possible treatment of Alzheimer\u2019s disease","volume":"19","author":"Vishwas","year":"2023","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.biopha.2023.115512_bib22","unstructured":"Statistics, Park. Found. (2023). \u3008https:\/\/www.parkinson.org\/understanding-parkinsons\/statistics\u3009 Accessed date 05\/06\/2023."},{"key":"10.1016\/j.biopha.2023.115512_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s40120-018-0091-2","article-title":"Parkinson\u2019s disease, the dopaminergic neuron and gammahydroxybutyrate","volume":"7","author":"Mamelak","year":"2018","journal-title":"Neurol. Ther."},{"key":"10.1016\/j.biopha.2023.115512_bib24","unstructured":"N. Javed, M. Cascella, Neuroanatomy, Globus Pallidus, StatPearls. (2023). \u3008https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557755\/\u3009 (accessed August 28, 2023)."},{"key":"10.1016\/j.biopha.2023.115512_bib25","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1749-6632.2003.tb07459.x","article-title":"Physiology and pathophysiology of Parkinson\u2019s disease","volume":"991","author":"Hamani","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2023.115512_bib26","first-page":"3","article-title":"Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis","author":"Kouli","year":"2018","journal-title":"Park. Dis. Pathog. Clin. Asp."},{"key":"10.1016\/j.biopha.2023.115512_bib27","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2023.115512_bib28","first-page":"2019","article-title":"Clinical profile of genetically proven huntington\u2019s","volume":"22","author":"Hussain","year":"2019","journal-title":"Dis. Patients East. India"},{"key":"10.1016\/j.biopha.2023.115512_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/B978-0-323-99616-7.00005-0","article-title":"Advanced drug delivery systems to treat Huntington\u2019s disease: challenges and opportunities","author":"Vishwas","year":"2022","journal-title":"Drug Deliv. Syst. Metab. Disord."},{"key":"10.1016\/j.biopha.2023.115512_bib30","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/mds.26001","article-title":"Genetic modifiers of Huntington\u2019s disease","volume":"29","author":"Gusella","year":"2014","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2023.115512_bib31","first-page":"16","article-title":"Phenotypic characterization of individuals with 30\u201340 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36\u201339 repeats","volume":"59","author":"Rubinsztein","year":"1996","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.biopha.2023.115512_bib32","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/mds.24024","article-title":"Age, CAG repeat length, and clinical progression in Huntington\u2019s disease","volume":"27","author":"Rosenblatt","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.biopha.2023.115512_bib33","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41467-021-21637-y","article-title":"Mutant Huntingtin stalls ribosomes and represses protein synthesis in a cellular model of Huntington disease","volume":"12","author":"Eshraghi","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2023.115512_bib34","first-page":"431","article-title":"Analysis of neurotransmitter metabolites and adenosine 3\u2032, 5\u2032-monophosphate in the CSF of patients with extrapyramidal motor disorders","volume":"40","author":"Cramer","year":"1984","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.biopha.2023.115512_bib35","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/hmg\/ddg046","article-title":"Specific progressive cAMP reduction implicates energy deficit in presymptomatic Huntington\u2019s disease knock-in mice","volume":"12","author":"Gines","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.biopha.2023.115512_bib36","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/mds.870010110","article-title":"Brain energy metabolism and dopaminergic function in Huntington\u2019s disease measured in vivo using positron emission tomography","volume":"1","author":"Leenders","year":"1986","journal-title":"Mov. Disord. J. Mov. Disord. Soc."},{"key":"10.1016\/j.biopha.2023.115512_bib37","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1212\/WNL.24.9.813","article-title":"Biochemical abnormalities in Huntington\u2019s chorea brains","volume":"24","author":"Srahl","year":"1974","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2023.115512_bib38","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for irnnairment of energy metabofism in vivo in Huntington\u2019s disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.biopha.2023.115512_bib39","first-page":"160","article-title":"Energy metabolism defects in Huntington\u2019s disease and effects of coenzyme Q10","volume":"41","author":"Koroshetz","year":"1997","journal-title":"Ann. Neurol. J. Am. Neurol. Assoc. Child Neurol. Soc."},{"key":"10.1016\/j.biopha.2023.115512_bib40","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/aps.2009.24","article-title":"Molecular mechanisms of excitotoxicity and their relevance to pathogenesis of neurodegenerative diseases","volume":"30","author":"Dong","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.biopha.2023.115512_bib41","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.mad.2008.11.006","article-title":"Aging: an important factor for the pathogenesis of neurodegenerative diseases","volume":"130","author":"Farooqui","year":"2009","journal-title":"Mech. Ageing Dev."},{"key":"10.1016\/j.biopha.2023.115512_bib42","first-page":"335","article-title":"Free radical damage and oxidative stress in Huntington\u2019s disease","volume":"83","author":"Borlongan","year":"1996","journal-title":"J. Fla. Med. Assoc."},{"key":"10.1016\/j.biopha.2023.115512_bib43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1159\/000072864","article-title":"Mechanisms of neuronal cell death in Huntington\u2019s disease","volume":"100","author":"Sawa","year":"2003","journal-title":"Cytogenet. Genome Res."},{"key":"10.1016\/j.biopha.2023.115512_bib44","doi-asserted-by":"crossref","first-page":"878","DOI":"10.3390\/molecules15020878","article-title":"3-Nitropropionic acid as a tool to study the mechanisms involved in Huntington\u2019s disease: past, present and future","volume":"15","author":"T\u00fanez","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115512_bib45","unstructured":"Who gets ALS?, ALS Assoc. (2023). \u3008https:\/\/www.als.org\/understanding-als\/who-gets-als\u3009 (Accessed date 12\/05\/2023)."},{"key":"10.1016\/j.biopha.2023.115512_bib46","unstructured":"Amyotrophic lateral sclerosis, Centers Dis. Control Prev. (2023). \u3008https:\/\/www.cdc.gov\/als\/WhatisALS.html\u3009 (Accessed date 15\/05\/2023)."},{"key":"10.1016\/j.biopha.2023.115512_bib47","unstructured":"Amyotrophic Lateral Sclerosis, Rare Dis. Disord. (2023). \u3008http:\/\/www.rarediseasesindia.org\/als\u3009 (Accessed date 15\/05\/2023)."},{"key":"10.1016\/j.biopha.2023.115512_bib48","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(14)70219-4","article-title":"Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study","volume":"13","author":"Al-Chalabi","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.biopha.2023.115512_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112818","article-title":"Pathophysiology and diagnosis of ALS: insights from advances in neurophysiological techniques","volume":"20","author":"van den Bos","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115512_bib50","doi-asserted-by":"crossref","first-page":"13602","DOI":"10.1021\/acs.jafc.2c04292","article-title":"Sesamol attenuates scopolamine-induced cholinergic disorders, neuroinflammation, and cognitive deficits in mice","volume":"70","author":"Yun","year":"2022","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2023.115512_bib51","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1039\/C8FO01436A","article-title":"Protective effects of sesamol on systemic oxidative stress-induced cognitive impairments: via regulation of Nrf2\/Keap1 pathway","volume":"9","author":"Ren","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.biopha.2023.115512_bib52","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1080\/10942912.2019.1656234","article-title":"The inhibition profile of sesamol against \u03b1-glycosidase and acetylcholinesterase enzymes","volume":"22","author":"Topal","year":"2019","journal-title":"Int. J. Food Prop."},{"key":"10.1016\/j.biopha.2023.115512_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113468","article-title":"Sesame oil mitigates memory impairment, oxidative stress, and neurodegeneration in a rat model of Alzheimer\u2019s disease. A pivotal role of NF-\u03baB\/p38MAPK\/BDNF\/PPAR-\u03b3 pathways","volume":"267","author":"Mohamed","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2023.115512_bib54","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3892\/etm.2017.4550","article-title":"Sesamol attenuates oxidative stress, apoptosis and inflammation in focal cerebral ischemia\/reperfusion injury","volume":"14","author":"Gao","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.biopha.2023.115512_bib55","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.biopha.2018.08.037","article-title":"Sesamin and sesamolin reduce amyloid-\u03b2 toxicity in a transgenic Caenorhabditis elegans","volume":"107","author":"Keowkase","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115512_bib56","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.1021\/acs.jafc.6b01237","article-title":"Effects of sesaminol feeding on brain A\u03b2 accumulation in a senescence-accelerated mouse-prone 8","volume":"64","author":"Katayama","year":"2016","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2023.115512_bib57","doi-asserted-by":"crossref","first-page":"6190","DOI":"10.1021\/acs.jafc.9b01436","article-title":"ApoE-dependent protective effects of sesamol on high-fat diet-induced behavioral disorders: regulation of the microbiome-gut-brain axis","volume":"67","author":"Yuan","year":"2019","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2023.115512_bib58","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.14260\/jemds\/2020\/857","article-title":"Development, characterization, and pharmacological investigation of sesamol and thymol conjugates of mefenamic acid","volume":"9","author":"B","year":"2020","journal-title":"J. Evol. Med. Dent. Sci."},{"key":"10.1016\/j.biopha.2023.115512_bib59","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1007\/s11033-022-07345-w","article-title":"The neuroprotective roles of dietary micronutrients on Parkinson\u2019s disease: a review","volume":"49","author":"Rahimmi","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.biopha.2023.115512_bib60","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1080\/26895293.2021.1994472","article-title":"Evaluating the synergistic effect of Mucuna prurines extract and sesame oil against the Parkinson\u2019s disease zebrafish model: in-vivo\/in-silico approach","volume":"14","author":"Dogra","year":"2021","journal-title":"All Life"},{"key":"10.1016\/j.biopha.2023.115512_bib61","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.biopha.2017.01.123","article-title":"Sesamin imparts neuroprotection against intrastriatal 6-hydroxydopamine toxicity by inhibition of astroglial activation, apoptosis, and oxidative stress","volume":"88","author":"Baluchnejadmojarad","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.biopha.2023.115512_bib62","series-title":"Handb. Res. Nat. Prod. Their Bioact. Compd. as Cancer Ther.","first-page":"399","article-title":"Anticancer Properties of Some Antioxidants","author":"Kapadia","year":"2022"},{"key":"10.1016\/j.biopha.2023.115512_bib63","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1016\/j.fct.2008.04.029","article-title":"The prophylactic protective effect of sesamol against ferric\u2013nitrilotriacetate-induced acute renal injury in mice","volume":"46","author":"Hsu","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2023.115512_bib64","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/01.shk.0000209552.95839.43","article-title":"Sesamol delays mortality and attenuates hepatic injury after cecal ligation and puncture in rats: role of oxidative stress","volume":"25","author":"Hsu","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.biopha.2023.115512_bib65","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1080\/10286020902862194","article-title":"Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats","volume":"11","author":"Kumar","year":"2009","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.biopha.2023.115512_bib66","doi-asserted-by":"crossref","first-page":"53767","DOI":"10.1007\/s11356-021-14587-x","article-title":"Neuroprotective effect of sesamol against aluminum nanoparticle-induced toxicity in rats","volume":"28","author":"Abou-Zeid","year":"2021","journal-title":"Environ. Sci. Pollut. Res."},{"key":"10.1016\/j.biopha.2023.115512_bib67","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1021\/acschemneuro.0c00824","article-title":"Protective effect of natural products against Huntington\u2019s disease: an overview of scientific evidence and understanding their mechanism of action","volume":"12","author":"Lum","year":"2021","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.biopha.2023.115512_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2022.120988","article-title":"Sesamol alleviates manganese-induced neuroinflammation and cognitive impairment via regulating the microglial cGAS-STING\/NF-\u03baB pathway","volume":"319","author":"Wu","year":"2023","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.biopha.2023.115512_bib69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1080\/1028415X.2019.1596613","article-title":"Sesamin and sesamol attenuate H2O2-induced oxidative stress on human neuronal cells via the SIRT1-SIRT3-FOXO3a signaling pathway","volume":"24","author":"Ruankham","year":"2021","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.biopha.2023.115512_bib70","doi-asserted-by":"crossref","first-page":"12717","DOI":"10.1021\/acs.jafc.1c04687","article-title":"Sesamol attenuates amyloid peptide accumulation and cognitive deficits in APP\/PS1 mice: the mediating role of the gut\u2013brain axis","volume":"69","author":"Liu","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2023.115512_bib71","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1021\/acs.jafc.9b07598","article-title":"Protective effects of sesamol on systemic inflammation and cognitive impairment in aging mice","volume":"68","author":"Ren","year":"2020","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.biopha.2023.115512_bib72","first-page":"930","article-title":"Effect of sesamol and folic acid on behavioural activity and antioxidant profile of rats induced with 6-hydroxy dopamine","volume":"6","author":"Khadira Sereen","year":"2014","journal-title":"Int. J. Pharmacogn. Phytochem. Res."},{"key":"10.1016\/j.biopha.2023.115512_bib73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.neuroscience.2013.09.029","article-title":"Sesamol and naringenin reverse the effect of rotenone-induced PD rat model","volume":"254","author":"Sonia Angeline","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2023.115512_bib74","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2217\/nnm.12.162","article-title":"Development and biological evaluation of Gymnema sylvestre extract-loaded nonionic surfactant-based niosomes","volume":"8","author":"Kamble","year":"2013","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2023.115512_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1081\/DDC-120001481","article-title":"Nanoparticle technology for drug delivery across the blood-brain barrier","volume":"28","author":"Lockman","year":"2002","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2023.115512_bib76","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.2217\/nnm-2017-0022","article-title":"The effect of nanoparticle size on the ability to cross the blood\u2013brain barrier: an in vivo study","volume":"12","author":"Betzer","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.biopha.2023.115512_bib77","doi-asserted-by":"crossref","first-page":"957","DOI":"10.2174\/1570159X18666201109090824","article-title":"Expanding the arsenal against Huntington\u2019s disease-herbal drugs and their nanoformulations","volume":"19","author":"Vishwas","year":"2020","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.biopha.2023.115512_bib78","first-page":"296","article-title":"Design, fabrication and characterization of sesamol loaded polymeric nanoparticles: in vivo hepatoprotective potential in Wistar rats","volume":"6","author":"Gupta","year":"2021","journal-title":"Nanomed. Res. J."},{"key":"10.1016\/j.biopha.2023.115512_bib79","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221810118","article-title":"Design and development of nanomaterial-based drug carriers to overcome the blood\u2013brain barrier by using different transport mechanisms","volume":"22","author":"Song","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2023.115512_bib80","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1039\/C9NR02710F","article-title":"Stochastic modeling of nanoparticle internalization and expulsion through receptor-mediated transcytosis","volume":"11","author":"Deng","year":"2019","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2023.115512_bib81","series-title":"Hybrid nanoparticles to cross the blood\u2013brain barrier","author":"Desai","year":"2022"},{"key":"10.1016\/j.biopha.2023.115512_bib82","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1016\/j.drudis.2021.04.008","article-title":"Recent advances in nano delivery systems for blood-brain barrier (BBB) penetration and targeting of brain tumors","volume":"26","author":"Reddy","year":"2021","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2023.115512_bib83","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/molecules25204781","article-title":"Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method","volume":"25","author":"Duong","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115512_bib84","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3109\/03639045.2014.938082","article-title":"PEGylated nanostructured lipid carriers (PEG\u2013NLC) as a novel drug delivery system for biochanin A","volume":"41","author":"Wang","year":"2015","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2023.115512_bib85","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jddst.2019.02.017","article-title":"Nanostructured lipid carriers (NLC) system: a novel drug targeting carrier","volume":"51","author":"Salvi","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2023.115512_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics12030288","article-title":"Nanostructured lipid carriers for delivery of chemotherapeutics: a review","volume":"12","author":"Haider","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115512_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40199-017-0191-z","article-title":"Application of nanostructured lipid carriers: the prolonged protective effects for sesamol in in vitro and in vivo models of ischemic stroke via activation of PI3K signalling pathway","volume":"25","author":"Hassanzadeh","year":"2017","journal-title":"DARU J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.115512_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics13081183","article-title":"Solid lipid nanoparticles (Slns): an advanced drug delivery system targeting brain through bbb","volume":"13","author":"Satapathy","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115512_bib89","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ejpb.2014.05.004","article-title":"Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art","volume":"87","author":"Gastaldi","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.biopha.2023.115512_bib90","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1124\/jpet.105.097139","article-title":"Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain","volume":"317","author":"Michaelis","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2023.115512_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2020.587997","article-title":"Solid lipid nanoparticles for drug delivery: pharmacological and biopharmaceutical aspects","volume":"7","author":"Scioli Montoto","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.biopha.2023.115512_bib92","doi-asserted-by":"crossref","first-page":"P199","DOI":"10.1016\/j.jalz.2012.05.544","article-title":"Neuroprotective potential of solid lipid nanoparticles of sesamol: possible brain targeting strategy","volume":"8","author":"Misra","year":"2012","journal-title":"Alzheimer\u2019s Dement"},{"key":"10.1016\/j.biopha.2023.115512_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14030572","article-title":"Pharmacokinetics and pharmacodynamics of intranasal solid lipid nanoparticles and nanostructured lipid carriers for nose-to-brain delivery","volume":"14","author":"Nguyen","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115512_bib94","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2014.11.014","article-title":"Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence","volume":"747","author":"Sachdeva","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115512_bib95","doi-asserted-by":"crossref","DOI":"10.3390\/nano12142337","article-title":"Inorganic nanomaterials versus polymer-based nanoparticles for overcoming neurodegeneration","volume":"12","author":"Martano","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2023.115512_bib96","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1089\/rej.2011.1193","article-title":"Delivery of sesamol-loaded solid lipid nanoparticles to the brain for menopause-related emotional and cognitive central nervous system derangements","volume":"14","author":"Kakkar","year":"2011","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.biopha.2023.115512_bib97","first-page":"1","article-title":"Micellar drug delivery systems based on natural biopolymers","volume":"13","author":"Atanase","year":"2021","journal-title":"Polym. (Basel)"},{"key":"10.1016\/j.biopha.2023.115512_bib98","first-page":"21","article-title":"Micellar drug delivery system: a review","volume":"2","author":"Kapare","year":"2020","journal-title":"Pharm. Reson."},{"key":"10.1016\/j.biopha.2023.115512_bib99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijbiomac.2021.06.171","article-title":"Sesamol-loaded stearic acid-chitosan nanomicelles mitigate the oxidative stress-stimulated apoptosis and induction of pro-inflammatory cytokines in motor neuronal of the spinal cord through NF-\u0138B signaling pathway","volume":"186","author":"Wang","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2023.115512_bib100","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.foodchem.2017.02.002","article-title":"Encapsulation of sesamol in phosphatidyl choline micelles: enhanced bioavailability and anti-inflammatory activity","volume":"228","author":"Yashaswini","year":"2017","journal-title":"Food Chem."},{"key":"10.1016\/j.biopha.2023.115512_bib101","first-page":"58","article-title":"Systematic development of transethosomal gel system of piroxicam: formulation optimization, in vitro evaluation, and ex vivo assessment","volume":"18","author":"Garg","year":"2017","journal-title":"AAPS\u00a0Pharmscitech"},{"key":"10.1016\/j.biopha.2023.115512_bib102","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2174\/1567201813666160520114436","article-title":"Ethosomes and transfersomes: principles, perspectives and practices","volume":"14","author":"Garg","year":"2017","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.biopha.2023.115512_bib103","doi-asserted-by":"crossref","first-page":"24","DOI":"10.14227\/DT170310P24","article-title":"Dissolution testing for poorly soluble drugs: a continuing perspective","volume":"17","author":"Gowthamarajan","year":"2010","journal-title":"Dissolution Technol."},{"key":"10.1016\/j.biopha.2023.115512_bib104","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/adt.2018.913","article-title":"Quality by design-based crystallization of curcumin using liquid antisolvent precipitation: micromeritic, biopharmaceutical, and stability aspects","volume":"18","author":"Som","year":"2020","journal-title":"Assay. Drug Dev. Technol."},{"key":"10.1016\/j.biopha.2023.115512_bib105","article-title":"Quantum dots: prospectives, toxicity, advances and applications","volume":"61","author":"Gidwani","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2023.115512_bib106","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2020.116013","article-title":"Role of quantum dots in pharmaceutical and biomedical analysis, and its application in drug delivery","volume":"131","author":"Bad\u0131ll\u0131","year":"2020","journal-title":"TrAC - Trends Anal. Chem."},{"key":"10.1016\/j.biopha.2023.115512_bib107","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.carbpol.2019.03.024","article-title":"Synthesis of CdS-modified chitosan quantum dots for the drug delivery of Sesamol","volume":"214","author":"Abdelhamid","year":"2019","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2023.115512_bib108","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ddr.21452","article-title":"Cyclodextrin complexes: perspective from drug delivery and formulation","volume":"79","author":"Jacob","year":"2018","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.biopha.2023.115512_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/scipharm87040033","article-title":"Cyclodextrins in drug delivery systems and their effects on biological barriers","volume":"87","author":"Haimhoffer","year":"2019","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.biopha.2023.115512_bib110","first-page":"1204","article-title":"Characterization and antioxidant activity of the complex of sesamol and hydroxypropyl-\u03b2-cyclodextrin","volume":"6","author":"Ma","year":"2012","journal-title":"Afr. J. Pharm. Pharmacol."},{"key":"10.1016\/j.biopha.2023.115512_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/nano12142440","article-title":"Nanosponges for drug delivery and cancer therapy: recent advances","volume":"12","author":"Iravani","year":"2022","journal-title":"Nanomaterials"},{"key":"10.1016\/j.biopha.2023.115512_bib112","first-page":"438","article-title":"A perspective view on nanosponge drug delivery system","volume":"14","author":"Dhanalakshmi","year":"2020","journal-title":"Drug Invent. Today"},{"key":"10.1016\/j.biopha.2023.115512_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcab.2022.102329","article-title":"Nanosponges as a biocatalyst carrier\u2014An innovative drug delivery technology for enzymes, proteins, vaccines, and antibodies","author":"Jani","year":"2022","journal-title":"Biocatal. Agric. Biotechnol."},{"key":"10.1016\/j.biopha.2023.115512_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.fbio.2021.101098","article-title":"Cyclodextrin decorated nanosponges of sesamol: antioxidant, anti-tyrosinase and photostability assessment","volume":"42","author":"Gupta","year":"2021","journal-title":"Food Biosci."},{"key":"10.1016\/j.biopha.2023.115512_bib115","doi-asserted-by":"crossref","first-page":"9823","DOI":"10.2147\/IJN.S279094","article-title":"A review on the synthesis and functionalization of gold nanoparticles as a drug delivery vehicle","volume":"15","author":"Amina","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2023.115512_bib116","article-title":"An overview of biomedical applications for gold nanoparticles against lung cancer","volume":"86","author":"Kumari","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.biopha.2023.115512_bib117","first-page":"213","article-title":"Neuroprotective effects of sesamol against LPS-induced spatial learning and memory deficits are mediated via anti-inflammatory and antioxidant activities in the rat brain","volume":"13","author":"Beheshtimanesh","year":"2023","journal-title":"Avicenna J.\u00a0Phytomedicine."},{"key":"10.1016\/j.biopha.2023.115512_bib118","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223013100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T21:42:32Z","timestamp":1776462152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223013100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":118,"alternative-id":["S0753332223013100"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115512","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harnessing role of sesamol and its nanoformulations against neurodegenerative diseases","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115512"}}